The ‘very, very bad look’ of remdesivir, the first FDA-approved COVID-19 drug | Science | AAAS

The ‘very, very bad look’ of remdesivir, the first FDA-approved COVID-19 drug | Science | AAAS: The Food and Drug Administration held no advisory meeting on antiviral, and the European Union signed contract without knowing of failed trial